RT Conference Proceedings
T1 The AXINET trial (GETNE1107): Axitinib plus octreotide LAR improves PFS by blinded central radiological assessment vs placebo plus octreotide LAR in G1-2 extrapancreatic NETs
A1 Garcia-Carbonero, R.
A1 Benavent, M.
A1 Fonseca, P. Jimenez
A1 Castellano, D.
A1 Alonso-Gordoa, T.
A1 Teule, A.
A1 Custodio, A.
A1 Tafuto, S.
A1 La Casta, A.
A1 Spada, F.
A1 Lopez, C.
A1 Ibrahim, T.
A1 Silva, M. J. Villanueva
A1 Iranzo, V.
A1 Garcia-Alfonso, P.
A1 Gonzalez-Flores, E.
A1 Grande, E.
A1 Crespo, G.
A1 Carmona-Bayonas, A.
A1 Capdevila, J.
PB Elsevier
SN 0923-7534
YR 2021
FD 2021-09-21
LK https://hdl.handle.net/10668/26495
UL https://hdl.handle.net/10668/26495
LA en
DS RISalud
RD Apr 18, 2025